Documentation for building strong cases encompasses the following elements: Prescription history showing Ozempic dosage, duration, and prescribing indication (diabetes versus weight loss) Emergency department records detailing acute symptom presentation and treatment Hospitalization records demonstrating severity through admission duration, IV hydration, nutritional support Diagnostic test results including gastric emptying studies, upper endoscopy ruling out obstruction, CT scans Gastroenterologist consultation notes confirming gastroparesis diagnosis Ongoing treatment records showing persistent symptoms and quality of life impacts Documentation of work absences, disability claims, or lifestyle modifications necessitated by symptoms Certain factors may disqualify or weaken potential claims, making early case evaluation
Saitman A, Park HD, Fitzgerald RL
Lunch: Grilled salmon (4 ounces) with a large mixed vegetable salad, including roasted beets, goat cheese crumbles, walnuts, and balsamic vinaigrette
Improved Metabolic Health Weight loss achieved through Semaglutide can contribute to better metabolic function, potentially reducing the risk of conditions such as diabetes, high blood pressure, and cardiovascular disease
Novo Nordisk faces competition from Eli Lilly's Zepbound and Mounjaro, as well as telehealth companies that sell compounded versions of Ozempic and Wegovy despite Food and Drug Administration restrictions on copycat medications